5 Trends Impacting Clinical Trials in 2020
Leaders will develop outcome-driven strategies emphasizing the importance of medications to providers, enabling strong payer partnerships and enhancing patient relationships.
I n 2020, the clinical trials industry will continue to focus its attention on value-based outcomes and on getting more real-world evidence. Leaders will develop outcome-driven strategies emphasizing the importance of medications to providers, enabling strong payer partnerships and enhancing patient relationships.
A greater attention to patient paves way for meaningful real-world data and better insights into therapy performance and medication adherence. Pharmaceutical companies want to know patients’ response to therapies and identify ideal subpopulations to eventually improve patient outcomes.
Combining data across provider, patient and pharma information on a single platform gives all stakeholders a unified view into actionable customer insights to improve commercial strategies to drive value.
Services that go over and beyond therapeutics offerings help accelerate revenues, especially with rising concerns of drug patient expirations and biosimilar products making their way into the market.
Clinical research organizations must now deliver value beyond pills while continuing to strengthen patient relationships. Reports suggest that less than half of patients (47%) said pharma companies understood their emotional, financial and other needs related to their condition. Offering value added services and personalized care and support gives the edge for clinical research organizations to win against this perception.
Also, advanced patient engagement strategies and solutions along with therapies help pharmaceutical companies gain that competitive edge: for instance, a mobile app that supports early screening/diagnosis or an app for clinical trials adherence goes a long way in building engagement, loyalty and trust.
Clinical Research Organizations are increasingly leveraging Cloud and AI technologies to increase operational efficiency, deliver actionable insights across R&D and commercial operations.
Structured and standardized data across providers, patients and pharma significantly reduces complexities broadening the horizons for possible innovation. Furthermore, leveraging AI to garner insights from that data fosters accelerated R&D, optimized clinical trials and better outcomes.
With significant changes driving focus on external innovation, cross-industry and cross- enterprise collaboration is becoming the new norm. To address the future needs of consumers, clinical trial organizations must leverage and scale with a platform that enables frictionless integrations. A 360-degree view into supply chain and manufacturing allows for connected experiences that facilitates cross-team and cross-industry partnerships.
From our humble beginnings as a healthcare start-up—to becoming a full-blown healthcare-exclusive digital transformation provider, our journey has been quite a remarkable one. Today, SolvEdge is a leading-edge Healthcare services and solutions provider—trusted by 450+ Hospitals, 3500+ Physicians and millions of patients across the globe.